Compare ABCB & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ABCB | GRFS |
|---|---|---|
| Founded | 1971 | 1940 |
| Country | United States | Spain |
| Employees | N/A | 25247 |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.1B | 5.4B |
| IPO Year | 2010 | N/A |
| Metric | ABCB | GRFS |
|---|---|---|
| Price | $85.47 | $7.64 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 7 | 2 |
| Target Price | ★ $87.14 | $10.15 |
| AVG Volume (30 Days) | 326.3K | ★ 607.3K |
| Earning Date | 04-23-2026 | 07-28-2022 |
| Dividend Yield | 0.95% | ★ 1.80% |
| EPS Growth | ★ 15.61 | N/A |
| EPS | ★ 1.63 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $14.70 | $4.49 |
| Revenue Next Year | $5.97 | $6.42 |
| P/E Ratio | $52.23 | ★ $18.67 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $59.54 | $7.39 |
| 52 Week High | $87.99 | $11.14 |
| Indicator | ABCB | GRFS |
|---|---|---|
| Relative Strength Index (RSI) | 55.61 | 41.27 |
| Support Level | $73.11 | $7.44 |
| Resistance Level | $86.16 | $8.24 |
| Average True Range (ATR) | 1.56 | 0.16 |
| MACD | -0.03 | -0.03 |
| Stochastic Oscillator | 88.01 | 24.07 |
Ameris Bancorp is a bank holding company that operates through Ameris Bank, its subsidiary. The company operates branches in Georgia, Alabama, Florida, and South Carolina. It offers traditional banking services such as business banking, personal banking, checking, savings, mobile banking, and others. The bank is organized into four segments: the Banking Division, the Retail Mortgage Division, the Warehouse Lending Division and the Premium Finance Division. The company generates majority of its revenue from the banking division. The company intends to acquire banks in its geographic region to increase its market share and expand beyond its current market.
Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.